Fc⑀RI-induced Ca2؉ signaling in mast cells is initiated by activation of cytosolic tyrosine kinases. Here, in vitro phospholipase assays establish that the phosphatidylinositol 3-kinase (PI 3-kinase) lipid product, phosphatidylinositol 3,4,5-triphosphate, further stimulates phospholipase C␥2 that has been activated by conformational changes associated with tyrosine phosphorylation or low pH. A microinjection approach is used to directly assess the consequences of inhibiting class IA PI 3-kinases on Ca 2؉ responses after Fc⑀RI cross-linking in RBL-2H3 cells. Injection of antibodies to the p110 or p110␦ catalytic isoforms of PI 3-kinase, but not antibodies to p110␣, lengthens the lag time to release of Ca 2؉ stores and blunts the sustained phase of the calcium response. Ca 2؉ responses are also inhibited in cells microinjected with recombinant inositol polyphosphate 5-phosphatase I, which degrades inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ), or heparin, a competitive inhibitor of the Ins(1,4,5)P 3 receptor. This indicates a requirement for Ins(1,4,5)P 3 to initiate and sustain Ca 2؉ responses even when PI 3-kinase is fully active. Antigeninduced cell ruffling, a calcium-independent event, is blocked by injection of p110 and p110␦ antibodies, but not by injection of 5-phosphatase I, heparin, or antip110␣ antibodies. These results suggest that the p110 and p110␦ isoforms of PI 3-kinase support Fc⑀RI-induced calcium signaling by modulating Ins(1,4,5)P 3 production, not by directly regulating the Ca 2؉ influx channel.Cross-linking of the high affinity receptor for IgE, Fc⑀RI, on mast cells results in the activation of tyrosine kinases Lyn and Syk, followed by tyrosine phosphorylation and activation of PLC␥ 1 isoforms and other downstream effectors (1). Subsequent hydrolysis of phosphatidylinositol 4,5-diphosphate by PLC␥ leads to the formation of Ins(1,4,5)P 3 , the release of Ca 2ϩ from internal stores (2), and the influx of Ca 2ϩ through storeoperated channels (3). Calcium influx, in turn, supports degranulation and the release of inflammatory mediators (4). This scenario was complicated in recent years by observations that PLC␥ activation and Ca 2ϩ responses and secretion are all diminished in mast cells treated with inhibitors of PI 3-kinases (5, 6). It was subsequently discovered that full activation of PLC␥ proteins in mast cells requires both tyrosine phosphorylation, potentially mediated by Tec family kinases (7), and interaction with the lipid products of PI 3-kinase (8). PtdIns(3,4,5)P 3 mediates membrane recruitment and phosphorylation of PLC␥1 in RBL-2H3 cells (8) and increases the activity of both PLC␥1 and PLC␥2 against lipid micelle substrates in vitro (9, 10).Despite demonstrated roles for PI 3-kinase in the activation of PLC␥, its specific contribution to the temporal regulation of Fc⑀RI-mediated Ca 2ϩ signaling is unresolved. Although wortmannin treatment can slightly increase the lag time leading to the initial rise in calcium after antigen stimulation, it does not block the initial response (1...